Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include RNA modifications and cancer, Cancer-related molecular mechanisms research, Hepatocellular Carcinoma Treatment and Prognosis, and Cholangiocarcinoma and Gallbladder Cancer Studies.
Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC
METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression
BMI1 Silencing Liposomes Suppress Postradiotherapy Cancer Stemness against Radioresistant Hepatocellular Carcinoma
METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
Methyltransferase 1 is required for nonhomologous end‐joining repair and renders hepatocellular carcinoma resistant to radiotherapy
N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression
METTL1 promotes hepatocarcinogenesis via m<sup>7</sup>G tRNA modification‐dependent translation control
Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6‐Methyladenosine mRNA Methylation‐Dependent Mechanism
Irreversible electroporation induces CD8+ T cell immune response against post-ablation hepatocellular carcinoma growth
Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI
Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation